Storyline Pros

Storyline Pros worked with N-Zyme Biomedical Inc., a biotechnology company in its clinical stage, focused on pioneering a way to monitor pepsin in reflux disease. The company was on a mission to revolutionize treatment regimens for patients dealing with symptoms inadequately addressed by conventional acid-suppression therapies. The company sought a partner who could help create awareness around its clinical development program and the introduction of its Phase II trial.

Storyline Pros, chosen for their compatible company culture, cost-effectiveness, and aligned values, became the strategic partner for N-Zyme. Their role involved the drafting and application of a focused media strategy to help N-Zyme reach its intended audience. They also worked to secure executive interviews, ensure industry media coverage, and communicate the importance and science of the company’s clinical program to those concerned.

Their services culminated in a successful marketing and PR campaign for the Biomedical company’s Phase 2 clinical trial. The tightly knit team of Storyline Pros—consisting of one committed employee—provided notable value in translating the technical and scientific aspects of N-Zyme's work into readily understandable summaries for public consumption. This helped facilitate stronger connections with relevant stakeholders and significantly elevated awareness of N-Zyme's innovative clinical development program.